Exploiting the timsTOF and Maldi-2 Platforms to Assess Pharmacodynamics and Pharmacokinetics in Preclinical Models

An integrated evaluation of the pharmacodynamic and pharmacokinetic properties of a drug is essential for successful translation to the clinic. However, cost-effective methods to measure these parameters at the systems level in pre-clinical models are lacking. Here, we introduce a timsTOF and MALDI-2 workflow to evaluate therapeutic activity. The platform combines ion mobility, mass spectrometry-based imaging, absolute drug quantitation across different biological matrices, in vivo isotope tracing, and global metabolome analysis in the adult zebrafish.

Attend this webinar to:

Learn about innovative metabolomics workflows
Discover how the Bruker timsTOF Pro and fleX systems can be used in metabolomics workflows
Learn how the MALDI-2 post-ionization laser can see never before observed compounds

*For Research Use Only. Not for use in diagnostic procedures.

Following our interaction with you, Bruker Daltonics and its affiliates within the Bruker group (“Bruker”) would like to be able to stay in contact with you and inform you about the latest technological achievements and upcoming events as well as the products and services offered by Bruker. If you are interested in hearing from us in the future, we will need your consent in accordance with applicable data protection laws to be allowed to engage in marketing activities using your contact information.
To view the promises that we make to you regarding your personal information, please view Bruker`s privacy polic y. For questions related to privacy, please send your inquiry to privacy@bruker.com
If you prefer not to receive promotional e-mails from Bruker in the future, you can unsubscribe at any time here.

Exploiting the timsTOF and MALDI-2 Platforms to Assess Pharmacodynamics and Pharmacokinetics in Preclinical Models